Shakun Sales Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.45 Cr
as on 16-07-2024
- Paid Up Capital ₹ 0.66 Cr
as on 16-07-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.94 Cr
as on 16-07-2024
- Satisfied Charges ₹ 8.48 Cr
as on 16-07-2024
- Revenue 19.40%
(FY 2023)
- Profit 116.65%
(FY 2023)
- Ebitda 122.65%
(FY 2023)
- Net Worth 9.89%
(FY 2023)
- Total Assets 25.23%
(FY 2023)
About Shakun Sales
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.45 Cr and a paid-up capital of Rs 0.66 Cr.
The company currently has active open charges totaling ₹19.94 Cr. The company has closed loans amounting to ₹8.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vishnu Shukla, Chetna Shukla, Sanwali Shukla, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397UP2003PTC028056
- Company No.
028056
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Uttar Pradesh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shakun Sales Private Limited offer?
Shakun Sales Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Pharmaceutical Chemists, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Infective Drugs & Medicines, Remdesivir Injection, Bevacizumab.
Who are the key members and board of directors at Shakun Sales?
Board Members(4)
Financial Performance and Corporate Structure Insights of Shakun Sales.
Shakun Sales Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.4% increase. The company also saw a substantial improvement in profitability, with a 116.65% increase in profit. The company's net worth moved up by a moderate rise of 9.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shakun Sales?
In 2023, Shakun Sales had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shakun Medicals Private Limited
Active
4 years 1 month Sanwali Shukla and Shakuntala Shukla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 03 Aug 2017 | ₹19.94 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Dec 2012 | ₹4.20 Cr | Satisfied |
Union Bank Of India Chandganj Branch Creation Date: 26 Jul 2012 | ₹1.30 M | Satisfied |
How Many Employees Work at Shakun Sales?
Shakun Sales has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Feb 17, 2016, Shakun Sales has raised a total of ₹ 8.36 M, with the most recent deal valued at ₹ 1.6 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
